CURE KIDS VENTURES LIMITED - Key Persons
Frances is CEO of Cure Kids. She has been a Director at Cure Kids Ventures since 2017. Frances has experience in fund raising, portfolio management, business planning, and sales & marketing from over 30 years within the pharmaceutical and fund raising industry. Frances is also highly passionate about the health and well-being of communities, which is an aptitude she garnered from working within Cure Kids and from being a former nurse.
Job Titles:
- CEO
- Chairman of the Board
- Director
- Chairman of Cure Kids Board
- Founding Chief Executive of the New Zealand Venture Investment Fund
Franceska is a recognised CEO, Chair and Director who has held board roles on many prominent New Zealand organisations. She brings extensive governance experience, spanning finance, technology and health sectors.
In 2016 Franceska was made an Officer of the NZ Order of Merit, for services to business and the community.
As Chair of Cure Kids Board, Franceska is committed to helping the organisation address some of the big health issues affecting kiwi children. This includes providing governance to Cure Kids Ventures for the successful commercialisation of research and technologies with the potential to benefit child health.
Job Titles:
- Director
- Member of the Board
Howard has been a Board Member at Cure Kids Ventures since 2008. Howard's breadth of experience spans multiple industries including venture capital, agritech, foodtech, and biotech. His career is hallmarked by fund raising, technology commercialisation, early stage company development and sales and marketing.
Matthew has twenty years' experience with high growth industries in New Zealand as advisor, investor, operator and entrepreneur. Highly skilled operator and analyst. Foundation team at NZ's first venture capital fund, No 8 Ventures. At BioDiscovery NZ Ltd raised $20m US venture finance over 3 years.
Matthew has spent more than 20 years in the global medical device industry. Over that time he has held a variety of roles in research and development, commercialisation and general management, including eight years in the senior leadership team at Fisher & Paykel Healthcare.
Michael joined Cure Kids Ventures as an Investment Analyst with early career experience in commercialisation and life-sciences consulting. He wrote his master's thesis on measuring the social impact of venture capital investments, a topic closely related to his work at CKV. Michael holds a Master of Bioscience Enterprise and a Bachelor of Science from the University of Auckland.